T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.2% |
| 3 | Consumer Discretionary | 15.17% |
| 4 | Financials | 10.75% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
National Health Investors
NHI
$3.53B
| $1.78M | ﹤0.01% |
30,102
+5,062
| +20% | +$288K |
|
1727
CytomX Therapeutics
CTMX
$719M
| $1.76M | ﹤0.01% |
661,063
+1,200
| +0.2% | +$4.61K |
|
|
MNDT
1728
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $1.76M | ﹤0.01% |
78,884
-68,457
| -46% | -$1.27M |
|
|
NVTA
1729
DELISTED
Invitae Corporation
NVTA
| $1.75M | ﹤0.01% |
220,156
-1,697,392
| -89% | -$17.1M |
|
1730
Avista
AVA
$3.25B
| $1.75M | ﹤0.01% |
38,792
-3,495
| -8% | -$154K |
|
1731
Rogers Corp
ROG
$2.52B
| $1.74M | ﹤0.01% |
6,420
-602
| -9% | -$164K |
|
|
HBI
1732
DELISTED
Hanesbrands
HBI
| $1.74M | ﹤0.01% |
117,072
+28,059
| +32% | +$441K |
|
1733
MGIC Investment
MTG
$6.37B
| $1.73M | ﹤0.01% |
127,850
+5,745
| +5% | +$86.1K |
|
1734
Fulton Financial
FULT
$4.73B
| $1.73M | ﹤0.01% |
103,975
+3,505
| +3% | +$62.7K |
|
|
COWN
1735
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $1.73M | ﹤0.01% |
63,668
+43,030
| +208% | +$1.31M |
|
1736
Credit Acceptance
CACC
$6.09B
| $1.72M | ﹤0.01% |
3,129
-182
| -5% | -$99.1K |
|
|
SFIX
1737
Stitch Fix
SFIX
$484M
| $1.72M | ﹤0.01% |
170,680
+13,559
| +9% | +$187K |
|
1738
Blackstone Mortgage Trust
BXMT
$2.46B
| $1.72M | ﹤0.01% |
53,961
-638,532
| -92% | -$20.1M |
|
1739
MDU Resources
MDU
$4.33B
| $1.72M | ﹤0.01% |
169,254
+21,788
| +15% | +$231K |
|
1740
Oceaneering
OII
$5.2B
| $1.72M | ﹤0.01% |
113,132
+4,253
| +4% | +$61.2K |
|
1741
Natera
NTRA
$44.5B
| $1.71M | ﹤0.01% |
42,081
-100,940
| -71% | -$6.07M |
|
|
LSXMA
1742
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $1.71M | ﹤0.01% |
50,969
+7,884
| +18% | +$277K |
|
1743
Vertiv
VRT
$113B
| $1.69M | ﹤0.01% |
120,882
+25,842
| +27% | +$459K |
|
|
MIME
1744
DELISTED
Mimecast Limited
MIME
| $1.69M | ﹤0.01% |
21,258
+3,720
| +21% | +$296K |
|
1745
Hilltop Holdings
HTH
$2.29B
| $1.69M | ﹤0.01% |
57,329
+1,946
| +4% | +$63.7K |
|
1746
MP Materials
MP
$10.4B
| $1.68M | ﹤0.01% |
29,207
+5,545
| +23% | +$244K |
|
|
VNE
1747
DELISTED
Veoneer, Inc.
VNE
| $1.67M | ﹤0.01% |
45,194
-4,500
| -9% | -$160K |
|
1748
Chegg
CHGG
$91.4M
| $1.67M | ﹤0.01% |
46,002
+3,773
| +9% | +$114K |
|
1749
Simmons First National
SFNC
$3.47B
| $1.67M | ﹤0.01% |
63,595
+2,178
| +4% | +$62.9K |
|
1750
GATX Corp
GATX
$6.34B
| $1.67M | ﹤0.01% |
13,507
+2,154
| +19% | +$236K |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.